3rd Annual Digi-Tech Pharma 2019
2019-05-21 - 2019-05-22 | London, United Kingdom
Our upcoming conference 3rd Annual Digi-Tech Pharma 2019 (Pharmaceutical technology conference 2019), will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of Digital Pharma IT. Also, to stay updated on the latest trends in digital, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the pharmaceutical conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.

NDD Europe 2019
2019-05-21 - 2019-05-23 | Hilton Paris La Defense, 2 Place de la Défense, 92800, Puteaux, France, France
Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics

Multiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success.
NDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers.
With 70+ thought-leaders converging at NDD Europe, this will be an unrivalled opportunity for you to gain the latest scientific insights, have your peers review your research and grow your collaborator network.

5th Precision CRISPR Genome Editing Congress
2019-05-21 - 2019-05-23 | The Westin Boston Waterfront, 425 Summer Street, Boston, MA, 02210, United States
Designed with CRISPR experts from AstraZeneca, AbbVie, Broad Institute, Casebia, Merck, Amgen and academics worldwide, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery, safety, precision, and efficiency to further optimize the relevant areas of drug discovery, functional screening & CRISPR-based cell & gene therapy.

Learn about how CRISPR is working in a clinical setting and unique approaches to gene therapy
Discover advances in disease modeling and strategies improving validation of human biology
Understand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox
Explore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases
Discover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline
Participate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR

With 100+ thought-leaders converging, this will surely be an unrivaled opportunity for you to gain the latest scientific insights into the ever-evolving CRISPR landscape and grow your collaborator network.
To learn more about this event, visit https://ter.li/tjkmgn

RE•WORK Deep Learning in Healthcare Summit, Boston
2019-05-23 - 2019-05-24 | InterContinental® Boston, 510 Atlantic Avenue, Massachusetts 02210
The Deep Learning in Healthcare Summit is returning to the east coast for the annual event in Boston! Hear from healthcare industry leaders, academics, researchers, and innovative startups working to advance deep learning technology and apply this within the health sector. Focusing on topics such as medical imaging, diagnostics, personalized medicine and how these are applied within pharmaceuticals, patient care, and health and wellbeing. The summit is a great way to discover the latest insights, evaluate your position within the industry and learn how the impacts can affect yourself and your work and provides an opportunity to network with other valued members of the community.
Discount Code: MP20

Microbiome Invest
2019-05-23 | London (Venue TBC)
Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.

Healthcare Market Access & Pricing World Summit
2019-05-28 - 2019-05-29 | NH Frankfurt Airport West Kelsterbacher Str. 19, 65479 Germany
The 2nd annual Healthcare Market Access & Pricing Summit is the meeting place for the Healthcare Pricing, Market Access, Reimbursement, HEOR, and RWE community.
Senior level experts from companies such as Abbott, Merck, Allergan, and Johnson & Johnson among others will give you valuable insights through various interactive sessions.
With hot session topics like biosimilars, orphan drugs and rare diseases, this conference will provide a total and complete insight into the latest developments in the healthcare space, may it be Pharma, MedTech, Biopharma or Biotech.
Join over 60+ healthcare professionals in May, and book your ticket now!

Skin Microbiome Congress
2019-05-29 - 2019-05-30 | Revere Hotel Boston Common, 200 Stuart St, Boston, MA, 02116, United States
Skin Microbiome Congress
Revere Hotel Boston Common 200 Stuart St, Boston, MA 02116, USA
29 – 30 May, 2019
“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!” – Mike Conti, Solabia

2018 saw the microbiome move to the forefront of over 300 industry leaders, who came together to exchange ideas at our Global Skin Microbiome Congress Series, the first dedicated congress focusing solely on Skin Microbiome.
With the microbiome set to be the biggest trend in skincare for 2019, we are incredibly excited to bring our flagship congress back to Boston, building on our success globally and connecting over 300 industry leaders.
This year, we take a deep-dive into the two key areas critical for success in this in this evolving field, with our 2 concurrent tracks of content. Track 1 will focus on developing a functional understanding of the microbiome, whereas track 2 will be focusing on building a commercial viable business.
Don’t miss the opportunity to join leading industry experts to explore next steps for skin microbiome research and development, as well as commercialization.
The inaugural Skin Microbiome Congress in 2018 SOLD OUT, don’t miss your chance to attend this year’s event!
To learn more about Skin Microbiome Congress, and to register online, visit www.skinmicrobiomecongress.com

Lyophilisation
2019-06-03 - 2019-06-04 | Holiday Inn Kensington Forum, 97 Cromwell Road, London, SW7 4DN, United Kingdom
SMi Presents their 7th Annual Lyophilisation Conference
SMi Group announces the return of the 7th Annual Lyophilisation Conference taking place on the 3rd and 4th June 2019, in London, UK.

Lyophilisation (or freeze drying) remains one of the most exciting and rapidly advancing technologies in the pharmaceutical industry to date. By 2020, the lyophilisation equipment market is projected to exceed 8% CAGR reaching approximately £4.4 billion.
Attend this conference along with key opinion leaders from all areas of pharmaceuticals and biologicals to explore formulation science, materials characterisation, novel and alternative technologies, mathematical modelling and regulatory updates.
How Will You Benefit?
Network and learn from leading professionals such as:
CHAIRS FOR 2019
Sune Klint Andersen, Principal Spray Drying, Janssen Pharmaceuticals
Xiaodong Chen, Senior Research Investigator, Bristol-Myers Squibb
KEY SPEAKERS INCLUDE:

Paul Matejtschuk, Principal Scientist & Section Head, Standardisation Science, NIBSC
Davide Fissore, Associate Professor, Politecnico di Torino
Michael Dekner, Head Fill & Finish LCM support, Takeda
Richard Denk, Head Sales Containment, Skan AG
Mostafa Nakach, Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D
Daryl Williams, Professor of Particle Science and Director of Discovery space, Imperial College London
Kevin Ward, Director of R&D, Biopharma technology
Paul Barry, Development Scientist, Genzyme Ireland Ltd/Sanofi

2019 HIGHLIGHTS

Explore the recent advances in lyophilisation methods and technologies from Biopharma Technology
Discuss the novel methods that characterise complex pharmaceutical products to aid formulation design from NIBSC
Gain insight into the approaches to avoid cross contamination during lyophilisation from SKAN AG
Discover a new approach towards process design through the use of micro freeze dryers by Politecno di Torino
Examine the use of model-based approach to lyophilisation cycle design from Takeda

For more information on 7th Annual Lyophilisation Conference, visit: www.lyophilisation-europe.com/PJ
Early-Bird Rates

BOOK BY 29TH MARCH AND SAVE £400
BOOK BY 30TH APRIL AND SAVE £200
BOOK BY 31ST MAY AND SAVE £100

Contact Info
T: +44 (0) 20 7827 6164
E: nhoward@smi-online.co.uk

Digital Pharma Europe
2019-06-04 - 2019-06-06 | Merck Serono Headquarters, Via Casilina 125, Rome, 00176, Italy
The 11th Digital Pharma Europe, hosted by Meck Serono in Rome, will focus on helping pharma understand how to evolve and adapt to the rapidly changing global healthcare ecosystem, and to the rapidly changing needs and dynamics of its customers. In essence: Understand Digital Marketing and the Evolution of The Engagement Model In The Era of AI.
To learn more about this event, and to register online, visit http://bit.ly/2UrQr1e

Clinical Trial Supply Southern California 2019
2019-06-05 - 2019-06-06 | Marriot Del Mar, San Diego, California
Facilitating a platform for the San Diego biotech hub to refine their clinical trial supply strategy to remain patient focused whilst staying at the forefront of an ever-changing landscape.
2019 will celebrate the 9th year Arena International brings the global Clinical Trial Supply series to San Diego, giving decision makers from small, medium and large pharmaceutical companies the opportunity to as inject agility, transparency and speed into your clinical trial supply.
This event brings the unique San Diego biotech hub together to discuss the best methodologies for ensuring successful clinical trial supply. We will focus on the full supply chain, starting with the front end all the way to site and direct to patient delivery. Delving into the finer details we will ensure the smooth running of trial supplies, to not only start and finish on time, but also to meet budgetary constraints.
Avoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions, roundtables, fireside chats and case studies to give rise to innovation solutions to existing challenges.
The key topics to be addressed will be:

Forecasting and Planning
Packaging and Labelling
Unique trial design e.g. adaptive, compassionate use and at home delivery
Brexit
New technologies

Join us in June in San Diego to be a part of the discussions and develop unique insight for clinical trial supply.

CPhI & P-MEC China 2019
2019-06-18 - 2019-06-20 | SNIEC, Shanghai, China
As the most comprehensive pharmaceutical exhibition in Asia, CPhI & P-MEC China has, since its launch in 2001, been fostering international pharmaceutical business exchanges and leading market trends and technical innovations in the entire industry. Based in Shanghai and with a global vision, CPhI & P-MEC China is emanating its influences by creating a trading & sourcing platform, gathering quality suppliers, sharing cutting-edge knowledge, and building up an elite pharma professional network.

CPhI & P-MEC China 2019 will be held in Shanghai on June 18-20, 2019. The annual pharma gala are expected to gather 70,000+ visits and showcase 3,200+ exhibitors in a 200,000+ square metre space. Welcome to join us in CPhI & P-MEC China 2019!

To learn more and to register online, visit: http://bit.ly/2r8jnuD

8th Annual HPAPI Summit
2019-06-19 - 2019-06-21 | The Westin Waltham Boston 70, Third Avenue Waltham,Boston Massachusetts 02451
Enabling Robust, Safe and Cost-Effective Productionof Highly Potent APIs
In the context of ever-increasing drug potency, the 8th Annual HPAPI Summit will provide you with real-world case-studies from the companies actively working with these compounds, enabling you to implement safe and robust practices in your own organization.
Incorporating insights from Genentech, Pfizer, Boehringer Ingelheim, SafeBridge and AbbVie, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly, safely and cost-effectively.

GI Inflammatory Diseases Summit (GIIDS)
2019-06-24 - 2019-06-26 | Revere Hotel Boston Common 200 Stuart Street Boston, MA, 02116 USA, MA, United States
Developing More Clinically Safe & Efficacious Therapeutics for GI Inflammatory Diseases
The GI Inflammatory Diseases Summit (GIIDS) focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe and efficacious therapeutics for Inflammatory Bowel Disease.
Incorporating insights from leading pharma and pioneering biotech, this discussion and networking forum will curate the cutting edge insights on:

Improving drug safety profiles of more gut-selective compounds
Optimizing trial design in a hypercompetitive market
The promise of microbiome based biotherapeutics

Join gastroenterology, immunology and anti-inflammatory drug developers at this unique conference and push the clinical frontier nearer to achieving significant clinical remission in larger groups of patients.

2nd Combination Products Lifecycle Management Summit
2019-06-25 - 2019-06-27 | Hyatt Regency Boston, One Ave. de Lafayette, Boston, MA, 02111, United States
Returning to Boston for its 2nd successful year in 2019, the CPLM Summit features a fresh speaker line-up including the FDA, Alnylam, kaleo, Novartis and many others, as well as a pre-conference focus day to give you a comprehensive LCM guide to your combination products.

Lifecycle management for drug-device combination product has stolen the spotlight amongst pharma, biotechs and device developers. Integrating multiple project teams and defining a common LCM program can be difficult – but there is a lot of potential and many benefits to having such a mind-set and implementing a robust LCM program from the get-go.
As the only peer-led community, we will bring in 100+ senior leaders from drug-device teams including the regulatory affairs, product development and quality to share their view and encourage collaborative efforts.
For more information on 2nd Annual CPLM Summit, visit https://ter.li/11hr26

Cell Engager Summit
2019-06-25 - 2019-06-27 | Revere Hotel Boston Common, 200 Stuart Street, Boston, MA, 02116, United States
The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic.

Overcome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug.
Discover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies.
With 22+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges.
Join us as we unite experts from across large pharma, innovative biotech and solution and service providers to bring to market safe and effective multi-specific immune cell engaging therapies.
To learn more and to register online, visit cell-engager-summit.com

4th Microbiome Movement – Drug Development Summit
2019-06-26 - 2019-06-28 | Revere Boston Common Hotel, 200 Stuart Street, Boston, MA, 02116, United States
4th Microbiome Movement – Drug Development Summit
June 26-28, 2019 | Boston, MA

Returning for the fourth year, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.
If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.
Hear from 60+ expert speakers including:

Alison Lawton, CEO, Kaleido Biosciences
Bernat Olle, CEO, Vedanta Biosciences
Cathryn Nagler, Bunning Food Allergy Professor, University of Chicago
Eric Shaff, CEO, Seres Therapeutics
Esi Lamouse-Smith, Director, Janssen Pharmaceuticals
Ken Blount, CSO, Rebiotix
Mike Romanos, CEO, Microbiotica
Ulrich Thienel, Chief Medical Officer, Finch Therapeutics Group

See the complete agenda and speaker list: https://ter.li/nefsqj
Early booking rates and group discounts are available. Visit the website to learn more: https://ter.li/1bcb5n.

The Pharma Gorilla
2019-06-26 | Le Meridien Singapore, Sentosa
After a successful and overwhelming response of the Pharma Gorilla conference Mumbai on March 27, The Conference Gorilla is organizing its 2nd and 3rd Edition of The Pharma on following dates and venues.

The Pharma Gorilla | June 26, 2019 | Le Meridien Singapore, Sentosa
The Pharma Gorilla | Nov 07, 2019 | New Delhi, India

The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends, advancements, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry.
The conference program have been designed in such way which can cover the trending topics under Keynote session, exclusive presentation, product lunch, panel and round table discussion and it also provides a meaningful information.
The Pharma Gorilla provides a perfect platform for conducting presentations, keynote sessions, sharing the knowledge, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition.
Target Audience: 150+ Pharma professional from all over the Asia so I think it would be a good platform for you to accomplish your networking with the key decision makers of pharmaceutical companies, software development companies, CRO, manufacturing, formulation, digital marketing and data management companies.
Glimpse of Conference Agenda!
Conference Panels

Artificial Intelligence in Pharma and Healthcare
A disruptive take on marketing: Digital Marketing comes to Pharma
Scope of E-Pharmacy in Asia: Bringing New Dimensions to Pharma Industry
Latest Trends in Formulation Development: A Global Perspective
The Impact of Regulatory Reform on Innovation in Drug Delivery Systems

Roundtable Discussion

Improving patient engagement and experience to improve clinical trials

Keynote Session

Innovation-driven and emerging technologies of Pharma Industry in Asia
The Global Pharma Industry: Policies, Regulations and Key Trends 2019-2020

Exclusive Presentation

Role of IPR in pharmaceutical industry
Career Growth Opportunities in the pharmaceutical industry
Improving Biosimilars in manufacturing data

For any query, contact us at contact@theconferencegorilla.com or IN: +91-813-004-7071 | US: +1-347-480-1588

Clinical Operations in Oncology Trials to East Coast 2019
2019-07-10 - 2019-07-11 | Boston, Massachusetts
Arena International is excited to announce the return of the 7th Annual Clinical Operations in Oncology Trials to the East Coast on July 10th-July 11th 2019.
As one of the only oncology operationally focused events in the East Coast, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage East Coast physicians and patients.
The event will be led by a myriad of industry specialists from the East Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion, spotlight Q&As, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market.
While maintaining the primary focus of its previous years, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry, and provide insight into the latest technological and therapeutic solutions.
This July prepare to hear from industry leading oncologists about accurate abidance to ICH E8 guidelines, effective oversight strategies, efficient trial designs and data management solutions. As pharmaceutical companies shift to conducting immuno-oncology trials and look towards how AI, data analytics and cutting edge technology can aid with early diagnosis, take this opportunity to stay updated with industry trends and showcase your innovative solutions to key decision makers.
We hope to see you in July, make sure to register your place today!

Indian Pharma Expo & Business Excellence Award 2019
2019-07-16 - 2019-07-18 | Hall no. 12-A, Pragati Maidan, New Delhi, Delhi, India
CIMS Medica presents the 8th edition of Indian Pharma Expo (IPE), scheduled to be held on 16th-18th July, 2019 at Hall No. 12-A, Pragati Maidan, New Delhi.

Previous year IPE set another successful milestone with presence of visitors from all parts of India and provided a common platform for promising sellers and potential buyers from Pharmaceutical and Healthcare Industries. With IPE, the benefits are bound to get augmented with presence of eminent personalities from various sectors of Pharma, non-pharma and healthcare industries. It will gather representation from various companies like Pharmaceutical manufacturers & marketers, packaging solution providers, machinery solution providers, franchise companies and many more under one roof.
The 3-day expo will bring together eminent personalities from various sectors of Pharmaceutical, non-pharma and healthcare industries. IPE 2019 is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnel who seek to buy bulk products on concessional rates.
This year IPE will be one point contact to exchange the business opportunities for National and International Pharmaceutical Companies. This event will prove to be a business expansion tool to many small-medium-major players in Pharmaceutical Industry.

PREDiCT: Tumor Models Boston
2019-07-16 - 2019-07-18 | Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States
The 7th Annual PREDiCT: Tumor Models Boston summit will explore robust preclinical strategies utilizing current and emerging model systems to overcome core challenges across the early stages of cancer drug development. Presentations will span preclinical strategies validating new anticancer drugs, assessing therapeutic index and identifying surrogate markers of tumor progression.

Plug into a network of preclinical and translational scientists seeking to share methods for the rational design of combinations, patient stratification and identify new strategies to model metastasis, resistance and sensitivity.
Why attend PREDiCT : Tumor Models Boston ?

35+ Preclinical & Translational Oncology Heads, each pioneering the further development and application of experimental models, will be sharing the latest insights on the impact of their work.
100+ senior level scientists from Sanofi, Kleo Pharmaceuticals, NIH, Dicerna, Pfizer, Crown Bioscience, The Jackson Laboratory, Eisai and many more are set to review the comparative cost-per-data point of next generation models alongside classical model-systems.
We’ll explore how classical and emerging models are evolving efficacy determination, biomarker discovery and combination therapies, allowing you to further develop your research and gain the best insight of the industry.

Download the full event guide to find out more!
To learn more about this event, and to register online, visit https://tumor-models.com/

IMPACCT: mHealth in Clinical Trials Summit
2019-07-16 - 2019-07-18 | The Westin Copley Place Boston, 10 Huntington Ave, Boston, MA, United States
The IMPACCT: mHealth in Clinical Trials series provides a dedicated forum for industry leaders in clinical and digital innovation to share data, best practice and game-changing approaches on how to transform the clinical research paradigm with digital technology and achieve true patient-centricity.
Join your peers and leading experts in this space for a collaborative discussion aiming to tackle key implementation challenges and accelerate the successful incorporation of innovative digital strategies in clinical R&D, to enhance patient experience and outcomes.
Industry leaders already confirmed include Novartis, AbbVie, the DiMe Society, Verily & many others.

2nd Neuropsychiatric Drug Development Summit
2019-07-23 - 2019-07-25 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
THE INDUSTRY’S DEFINITIVE MEETING TO ADVANCE THE DEVELOPMENT OF CLINICALLY TRANSFORMATIVE NEUROPSYCHIATRIC DRUGS

With the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available, the development of the next generation of neuropsychiatric drugs is essential.
The abundance of excitement and scientific progress in the field – especially with the recent approval of esketamine – will be captured at the Neuropsychiatric Drug Development summit, in Boston on July 23 – 25, 2019.
Built with thought-leaders at Sage Therapeutics, Johnson & Johnson and Lundbeck, the 2nd Annual NPD summit will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs.
Dedicated to overcoming challenges in neuropsychiatric drug development, this comprehensive discussion and networking forum will cover:

Reviewing the current clinical landscape to share learned lessons, predict potential success and identify future opportunities
Determine what we can expect from neuropsychiatric preclinical models to better predict clinical efficacy
Utilize what we know from the clinical to improve our use of translational strategies
Discuss the potential for digital therapeutics to transform the success of efficacious pharmaceuticals
Review symptomatic focused drug development to identify the benefits and impact future regulation
Evaluate the potential for different neuropsychiatric targets by improving our understanding of neuropsychiatric biology
Improving our understanding of the role of genetics in neuropsychiatry and debating the future of precision medicine for neuropsychiatric disorders

Join your peers at NPD to be part of the cross-industry discussion on latest developments, insights and science to elevate clinically effective neuropsychiatric therapeutic pipelines
To learn more about this event, visit https://ter.li/belugv

B3DD Summit
2019-08-13 - 2019-08-15 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
The Blood-Brain Barrier Delivery Summit (B3DD) is the industry’s first conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates.

With an emphasis on biologics, and built with the field’s leading minds from the likes of Biogen, Genentech, Armagen & Denali, the B3DD Summit will unite over 60 industry stakeholders giving you the opportunity to develop new partnerships and build on existing relationships to ensure you have the connections to accelerate your drug’s development.
Some of the highlights include:

Assessing Microphysiological Models of the BBB – Biogen
Employing in vivo Microdialysis & Microperfusion Methods to Understand Brain Disposition of Biologics for the Treatment of CNS Disorders – AbbVie
Clinical Efficacy of Antibody-enzyme Fusion Proteins as Carrier Platform to Transport Lysosomal Enzymes Across the BBB for the Treatment of Mucopolysaccharidosis Type I
PKPD of Different Therapeutic Modalities for CNS Indications – Genentech
Explaining Clinical Failures – Is Efficacy or Delivery to Blame?- Merck, Lundbeck, AbbVie

To learn more about B3DD Summit, and to register online, visit https://ter.li/7vs04e

2nd Annual Hemophilia Drug Development Summit
2019-08-20 - 2019-08-22 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
Given the excitement and anticipation of increasingly more promising prophylactic treatments and gene therapies, the 2nd Annual Hemophilia Drug Development Summit, once again unites leading pharma, biotech and academic KOLs working to translate and clinically develop longer acting and more efficacious therapies to overcome significant unmet medical need and hemophilia and other bleeding disorders.

Attend the 2nd Hemophilia Drug Development Summit to identify novel drug development strategies and overcome the shared translational, clinical development and delivery challenges to dramatically improve patient outcomes.
Sounds interesting? Find out more – get free event brochure here: https://ter.li/4snxn9

4th Annual Medical Device Regulatory and Quality Summit 2019
2019-08-22 - 2019-08-23 | New Delhi, India
4th Annual Medical Device Regulatory and Quality Summit 2019 will create a platform for regulators, industry stalwarts to come under one roof to discuss and share ideas that would not only benefit their organisations, but at large the industry as well. The 4th Annual Medical Device Regulatory and Quality Summit 2019 will review the evolving regulations, their impact on the industry as well as take an in depth look into areas of quality control and assurance.

To learn more about this event, and to register online, visit http://bit.ly/2MgH15z

3rd Annual IPF Summit
2019-08-27 - 2019-08-29 | Sheraton San Diego Hotel & Marina, 1380 Harbor Island Drive, San Diego, CA, 92101, United States
The IPF Summit focuses exclusively on closing the translational gap between preclinical predictability and clinical attrition to accelerate the development of truly curative idiopathic pulmonary fibrosis (IPF) therapeutics.

With the 2019 conference expanding upon an even greater breadth and depth of content, you’ll hear three days of unrivalled scientifically driven and case-study based analysis and discussion, as together leading academia and biopharma advance the IPF drug development frontier.
Last year, over 90 of IPF’s expert drug developers came together to advance the standardisation of imaging, share clinical insights, and evaluate better recapitulating disease physiology in vitro exclusively for IPF:
“This was a superb meeting combining several emerging themes in IPF therapies and a dynamic mix of formal presentations with impromptu networking. All the speakers were excellent, and every session provided novel and important insight regarding IPF. The effort the speakers put into their presentations was evident. Great job!”
Ceders-Sinai Medical Center
With the incredible breakthrough success of drugs now in our arsenal for slowing IPF disease progression, the increasing importance of identifying genetic mechanisms, closing the translational gap between preclinical and clinical results, and developing candidates to reverse fibrosis have opened up further challenges within IPF drug development.
Join “part 3” as the IPF community converges again to:

Analyze the latest understanding of IPF pathology for improved target validation of next generation therapeutics and the potential to promote tissue regeneration to achieve reversal of fibrosis
Critically discuss how to design the next generation of phase III clinical trials for candidate success in light of a current standard of care
Outline progressions in the standardization of imaging and advancements of biomarkers to improve translational success and more confident diagnosis of patients

To learn more about 3rd Annual IPF Summit and to register online, visit https://ter.li/i81anp
Contact
Email – info@hansonwade.com
Phone – +1 415 735 3289

2nd Microbiome Movement - Skin Health & Dermatology Summit
2019-09-04 - 2019-09-06 | The Westin San Diego, 400 West Broadway, San Diego, CA, 92101, United States
2nd Microbiome Movement – Skin Health & Dermatology Summit
Translate the Skin Microbiome into Safe, Effective & Commercially Viable Dermatological Therapeutics & Cosmetic Products
4-6 September 2019 | San Diego
Website: https://ter.li/bsl3rt
As scientific researchers continue to investigate the complexities of the skin microbiome, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple: Build a collaborative forum that unites forward thinking academic, dermatological & cosmetic researchers, and lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing solutions that modify the skin microbiome to treat disease (therapeutics) or support overall skin health (cosmetics).

Our conversations have highlighted that although a strong commercial opportunity exists, there are critical areas of basic science that need addressing including study design to elucidate host-microbiome interactions, selecting the right tools to make clear correlations between microbial dysbiosis and skin disease and standardization of sample collection and analysis.
If you’re keen to make sense of skin microbiome science and its application to the therapeutic and cosmetic industry, join over 100+ scientifically-driven researchers from academia, biopharma and the cosmetic community to help you discover, translate and commercialize breakthrough therapeutics or cosmetics that improve skin health.
Early booking and group discounts are available. Visit the website to learn more: https://ter.li/bsl3rt

3D Tissue Models Summit
2019-09-04 - 2019-09-06 | Hilton Boston Back Bay 40 Dalton St Boston, MA 02115, USA
The 3D Tissue Models Summit will bring together 120+ industry stakeholders across the regulatory, pharma, biotech and academic landscapes to discuss the latest insight into established validation techniques to increase reproducibility and improve the preclinical effectiveness of drug candidates.
Join us and discover:
20+ latest case studies showcasing the advantages of high throughput screening techniques across the 3D model continuum to drive drug discovery progress.
FDA guidance into the regulatory landscape to define a common language of key terms across the industry for end users.
NIH and IQ Consortia discussing the latest developments to incorporate platform-specific standardization and reproducibility metrics for organoids and tissue chip technology.
Model developers and academic experts revealing how to overcome translational challenges to define disease-relevant endpoints across a variety of model types.
Take advantage of this unrivalled learning and networking opportunity packed with content and dedicated interactive formats to ensure you leave equipped with the connections and takeaways to enhance the predictive success of your preclinical 3D models.

Pharma and Device Packaging and Labelling Europe 2019
2019-09-10 - 2019-09-11 | Munich, Germany
After a successful European launch, a special thank you to all our attendees at the Pharma Packaging and Labelling Conference! Arena International is delighted to announce we will be returning to Munich in 2019 for another superb year.
We have welcomed more than 100 attendees from across the region for two days of engaging presentations from the biggest names in the sector.
The 2018 programme looked at ongoing regulations, ensuring patient safety and making sure the right systems are in place which is more crucial than ever with the ever looming FMD regulations. Top pharmaceutical companies, biotechs, CMOs and medical device companies such as Abbott, Sandoz, Coloplast, AbbVie, Novartis, Roche; including regulatory bodies GS1, EAASM and many more came together to share their insights into compliant packaging and labelling implementation.
Pharma Packaging and Labelling Europe will be returning in September 2019. We look forward to seeing you all there!

5th Annual CAR-TCR Summit
2019-09-10 - 2019-09-13 | Seaport Hotel & World Trade Center, One Seaport Lane, Boston, MA, 02210, United States
The definitive, world-renowned summit dedicated to providing comprehensive insight into the full end-to-end pharmaceutical value chain for CAR-TCR therapies in liquid and solid tumor indications.
The CAR-TCR Summit remains at the forefront of the industry bringing you never-seen-before data from the movers and shakers in CAR and TCR therapy development.

Dedicated to discussing the next generation candidates beyond CD19, from solid tumor indications to autoimmune disorders, this meeting provides an in depth breakdown of the current strategies to optimize the durability, persistence and targeting of approved and novel therapies to reduce relapse rates and overcome toxicity.
At the premier, end-to-end summit focused on early research through to commercialization, join the experts to discuss how to streamline process development and logistics supply chains for affordable and accessible CAR-TCR therapeutics.
Take advantage of the unrivalled networking opportunities as we bring together over 1000 industry leaders developing CAR-TCR based therapies from across pharma, biotech, regulatory bodies, academia, solution and service providers.
Here’s a snapshot of the 140+ world class speaker faculty:

James Noble, Chief Executive Officer, Adaptimmune
Barbra Sasu, Chief Scientific Officer, Allogene
Chris Haqq, Chief Scientific Officer, Atara Biotherapeutics
Elsy Boglioli, Chief Operating Officer, Cellectis
Jean-Pierre Latere, Chief Operations Officer, Celyad
Katherine Szarama, Evidence Development Division, Coverage & Analysis Group, Center for Clinical Standards and Quality, Centers for Medicare & Medicaid Services
Cheng Liu, Chief Executive Officer, Eureka Inc.
Jason Krentz, Chief Technology Officer, Tmunity Therapeutics
Thomas Andresen, Chief Scientific Officer, Torque Therapeutics
Matthew Spear, Chief Medical Officer, Poseida Therapeutics

Download the event guide for the full details of the speaker line-up, agenda and discounts available.
